Cargando…
Caspase-1 genetic variation is not associated with Alzheimer's disease risk
BACKGROUND: Interleukin (IL)-1β is a potent proinflammatory cytokine markedly overexpressed in the brains of patients with Alzheimer's disease (AD), and also involved in development of atherosclerosis and coronary artery disease. Caspase-1 (CASP1), formerly called IL-1β converting enzyme (ICE),...
Autores principales: | Vázquez-Higuera, José Luis, Rodríguez-Rodríguez, Eloy, Sánchez-Juan, Pascual, Mateo, Ignacio, Pozueta, Ana, Martínez-García, Ana, Frank, Ana, Valdivieso, Fernando, Berciano, José, Bullido, María J, Combarros, Onofre |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837022/ https://www.ncbi.nlm.nih.gov/pubmed/20184726 http://dx.doi.org/10.1186/1471-2350-11-32 |
Ejemplares similares
-
Genetic variation in the tau protein phosphatase-2A pathway is not associated with Alzheimer's disease risk
por: Vázquez-Higuera, José L, et al.
Publicado: (2011) -
DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2009) -
Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test
por: Pozueta, Ana, et al.
Publicado: (2011) -
No association of CDK5 genetic variants with Alzheimer's disease risk
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2009) -
Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET
por: López-de-Eguileta, Alicia, et al.
Publicado: (2019)